
    
      This is a randomized, double-blind, crossover study to evaluate chlorthalidone and
      hydrochlorothiazide and their effects on endothelial function in hypertensive patients.
      Subjects will receive chlorthalidone 12.5 mg, hydrochlorothiazide 25 mg, and placebo each for
      4 weeks with a 1 week washout between study periods. Sequence of study drugs will be
      randomized. Flow mediated vasodilatation will be measured at baseline and after each
      treatment period.
    
  